Literature DB >> 9881962

Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.

M Le Hir1, C Haas, M Marino, B Ryffel.   

Abstract

Tumor necrosis factor (TNF) is a proinflammatory cytokine playing a central role in the expression of endothelial adhesion molecules required for the recruitment of inflammatory cells. Proliferative glomerulonephritis induced by anti-glomerular basement membrane (GBM) antibody is characterized by the recruitment of inflammatory cells in the glomerulus followed by capillary damage and crescent formation. The glomerular pathology may be due to a large extent to TNF induction. We therefore tested this hypothesis in TNF-deficient mice. Anti-GBM antibody administration in sensitized wild-type mice resulted in deposition of immune complexes, followed by increased intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression, as well as the influx of polymorphonuclear neutrophils (PMNs), lymphocytes, and macrophages. Distinct proteinuria preceded proliferative glomerulonephritis characterized by crescent formation. In the absence of TNF, the development of proteinuria was delayed and the formation of crescents was almost completely prevented. Although the deposition of immune complexes in glomeruli was comparable in both groups, the up-regulation of ICAM-1 and VCAM-1, as well as the influx of PMNs and lymphocytes, but not of monocytes, was dramatically reduced in TNF-deficient mice. Therefore, we conclude that TNF plays a key role in the recruitment of inflammatory cells and in the subsequent development of proliferative glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881962

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  25 in total

1.  Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.

Authors:  Maki Urushihara; Naro Ohashi; Kayoko Miyata; Ryousuke Satou; Omar W Acres; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

2.  NKT cells inhibit the development of experimental crescentic glomerulonephritis.

Authors:  Seung Hee Yang; Su Jin Kim; Nakkyung Kim; Ji Eun Oh; Jung Gil Lee; Nam Hyun Chung; Suhnggwon Kim; Yon Su Kim
Journal:  J Am Soc Nephrol       Date:  2008-06-04       Impact factor: 10.121

Review 3.  The role of necrotic cell death in the pathogenesis of immune mediated nephropathies.

Authors:  Neelakshi R Jog; Roberto Caricchio
Journal:  Clin Immunol       Date:  2014-05-17       Impact factor: 3.969

4.  Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.

Authors:  Maki Urushihara; Hiroyuki Kobori
Journal:  Int J Clin Med       Date:  2011-09-01

5.  No association of monocyte chemoattractant protein-1 -2518 A/G polymorphism with the risk of primary glomerulonephritis in the Polish population.

Authors:  Magdalena Mostowska; Margarita Lianeri; Andrzej Oko; Adrianna Mostowska; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

6.  Inflammatory markers and the risk of hip fracture: the Women's Health Initiative.

Authors:  Kamil E Barbour; Robert Boudreau; Michelle E Danielson; Ada O Youk; Jean Wactawski-Wende; Nancy C Greep; Andrea Z LaCroix; Rebecca D Jackson; Robert B Wallace; Douglas C Bauer; Matthew A Allison; Jane A Cauley
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

7.  Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.

Authors:  P S Topham; V Csizmadia; D Soler; D Hines; C J Gerard; D J Salant; W W Hancock
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

8.  Alteration of podocytes in a murine model of crescentic glomerulonephritis.

Authors:  Valérie Besse-Eschmann; Michel Le Hir; Nicole Endlich; Karlhans Endlich
Journal:  Histochem Cell Biol       Date:  2004-08       Impact factor: 4.304

Review 9.  Anti-TNF-alpha therapies in systemic lupus erythematosus.

Authors:  Lang-Jing Zhu; Xiao Yang; Xue-Qing Yu
Journal:  J Biomed Biotechnol       Date:  2010-06-22

10.  Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation.

Authors:  Neelakshi R Jog; Joudy-Ann Dinnall; Stefania Gallucci; Michael P Madaio; Roberto Caricchio
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.